Patents Assigned to Tranxenogen
  • Nuclear reprogramming using cytoplasmic extract
    Patent number: 6753457
    Abstract: The present invention concerns products and methods particularly useful for activating and analyzing non-dividing cell nuclei. The featured products include activating egg extracts, cytostatic factor (CSF) extracts, kits containing these extracts, and a microchamber microscope slide useful in analyzing nucleus activation.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: June 22, 2004
    Assignee: Tranxenogen
    Inventor: Lawrence J. Wangh